Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $156.8 million.

  • BIO-TECHNE's Shares Outstanding (Weighted Average) fell 1.92% to $155.5 million in Q3 2025 from the same period last year, while for Dec 2021 it was $157.2 million, marking a year-over-year increase of 1.78%. This contributed to the annual value of $156.8 million for FY2025, which is 0.52% down from last year.
  • BIO-TECHNE's Shares Outstanding (Weighted Average) amounted to $156.8 million in FY2025, which was down 0.52% from $157.6 million recorded in FY2024.
  • BIO-TECHNE's 5-year Shares Outstanding (Weighted Average) high stood at $157.6 million for FY2024, and its period low was $155.6 million during FY2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $157.3 million, with a median of $157.4 million in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first increased by 1.75% in 2021, then fell by 0.52% in 2025.
  • BIO-TECHNE's Shares Outstanding (Weighted Average) (Yearly) stood at $155.6 million in 2021, then grew by 0.88% to $156.9 million in 2022, then increased by 0.32% to $157.4 million in 2023, then rose by 0.09% to $157.6 million in 2024, then fell by 0.52% to $156.8 million in 2025.